Asset Management One
CYTK icon

Asset Management One’s Cytokinetics CYTK Stock Holding History

Asset Management One’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-18,373
Closed -$174K – 1319
2016
Q2 		$174K Sell
18,373
-69,751
-79% -$572K ﹤0.01% 1216
2016
Q1 		$621K Hold
88,124
– – 0.01% 1015
2015
Q4 		$922K Buy
+88,124
New +$864K 0.01% 893

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Asset Management One's CYTK Position: Q3 2016 in Review

Asset Management One sold out of Cytokinetics (CYTK) in Q3 2016, closing a stake of 18,373 shares — an estimated $174K sold.

Asset Management One first reported a position in CYTK in Q4 2015 and held it in 3 quarters. The position peaked at $922K in Q4 2015. 91 funds tracked by Wall St. Rank hold CYTK as of Q3 2016.

  • Asset Management One reported no remaining Cytokinetics position as of Q3 2016 after selling out during the quarter.
  • Asset Management One sold 18,373 Cytokinetics shares in Q3 2016, an estimated $174K.
  • Asset Management One first reported a position in Cytokinetics in Q4 2015 and held it in 3 quarters.
  • Asset Management One's Cytokinetics position peaked at $922K in Q4 2015.
  • 91 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2016.

Based on Asset Management One's 13F filing for Q3 2016, filed 7 Nov 2016.